http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2431888-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e253661ef0079638605fe5e327287a8f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
filingDate 2001-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20b179a8d87229f3f70c51d2fe142448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce7b7a9e7ea39bb6caeca4f19398027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a9791997811b36dd2726b51458231ad
publicationDate 2002-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2431888-A1
titleOfInvention Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
abstract Lipid nanoparticles loaded with drugs, such as peptides or proteins, are herein described. A process for obtaining them as well as their use for the preparation of a pharmaceutical composition is also disclosed. According to a preferred embodiment, the drug is a LHRH analogue, more preferably a LHRH antagonist, and the lipid matrix comprises at least 70% w/w of monoglyceride s.
priorityDate 2000-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451367506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44354963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423271027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23670522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25074887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451265449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408497310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449868975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107767

Total number of triples: 53.